Cargando…
Mechanisms of Immunosuppressive Tumor Evasion: Focus on Acute Lymphoblastic Leukemia
Acute lymphoblastic leukemia (ALL) is a malignancy with high heterogeneity in its biological features and treatments. Although the overall survival (OS) of patients with ALL has recently improved considerably, owing to the application of conventional chemo-therapeutic agents, approximately 20% of th...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636671/ https://www.ncbi.nlm.nih.gov/pubmed/34867958 http://dx.doi.org/10.3389/fimmu.2021.737340 |
_version_ | 1784608575130173440 |
---|---|
author | Jiménez-Morales, Silvia Aranda-Uribe, Ivan Sammir Pérez-Amado, Carlos Jhovani Ramírez-Bello, Julian Hidalgo-Miranda, Alfredo |
author_facet | Jiménez-Morales, Silvia Aranda-Uribe, Ivan Sammir Pérez-Amado, Carlos Jhovani Ramírez-Bello, Julian Hidalgo-Miranda, Alfredo |
author_sort | Jiménez-Morales, Silvia |
collection | PubMed |
description | Acute lymphoblastic leukemia (ALL) is a malignancy with high heterogeneity in its biological features and treatments. Although the overall survival (OS) of patients with ALL has recently improved considerably, owing to the application of conventional chemo-therapeutic agents, approximately 20% of the pediatric cases and 40–50% of the adult patients relapse during and after the treatment period. The potential mechanisms that cause relapse involve clonal evolution, innate and acquired chemoresistance, and the ability of ALL cells to escape the immune-suppressive tumor response. Currently, immunotherapy in combination with conventional treatment is used to enhance the immune response against tumor cells, thereby significantly improving the OS in patients with ALL. Therefore, understanding the mechanisms of immune evasion by leukemia cells could be useful for developing novel therapeutic strategies. |
format | Online Article Text |
id | pubmed-8636671 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86366712021-12-03 Mechanisms of Immunosuppressive Tumor Evasion: Focus on Acute Lymphoblastic Leukemia Jiménez-Morales, Silvia Aranda-Uribe, Ivan Sammir Pérez-Amado, Carlos Jhovani Ramírez-Bello, Julian Hidalgo-Miranda, Alfredo Front Immunol Immunology Acute lymphoblastic leukemia (ALL) is a malignancy with high heterogeneity in its biological features and treatments. Although the overall survival (OS) of patients with ALL has recently improved considerably, owing to the application of conventional chemo-therapeutic agents, approximately 20% of the pediatric cases and 40–50% of the adult patients relapse during and after the treatment period. The potential mechanisms that cause relapse involve clonal evolution, innate and acquired chemoresistance, and the ability of ALL cells to escape the immune-suppressive tumor response. Currently, immunotherapy in combination with conventional treatment is used to enhance the immune response against tumor cells, thereby significantly improving the OS in patients with ALL. Therefore, understanding the mechanisms of immune evasion by leukemia cells could be useful for developing novel therapeutic strategies. Frontiers Media S.A. 2021-11-18 /pmc/articles/PMC8636671/ /pubmed/34867958 http://dx.doi.org/10.3389/fimmu.2021.737340 Text en Copyright © 2021 Jiménez-Morales, Aranda-Uribe, Pérez-Amado, Ramírez-Bello and Hidalgo-Miranda https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Jiménez-Morales, Silvia Aranda-Uribe, Ivan Sammir Pérez-Amado, Carlos Jhovani Ramírez-Bello, Julian Hidalgo-Miranda, Alfredo Mechanisms of Immunosuppressive Tumor Evasion: Focus on Acute Lymphoblastic Leukemia |
title | Mechanisms of Immunosuppressive Tumor Evasion: Focus on Acute Lymphoblastic Leukemia |
title_full | Mechanisms of Immunosuppressive Tumor Evasion: Focus on Acute Lymphoblastic Leukemia |
title_fullStr | Mechanisms of Immunosuppressive Tumor Evasion: Focus on Acute Lymphoblastic Leukemia |
title_full_unstemmed | Mechanisms of Immunosuppressive Tumor Evasion: Focus on Acute Lymphoblastic Leukemia |
title_short | Mechanisms of Immunosuppressive Tumor Evasion: Focus on Acute Lymphoblastic Leukemia |
title_sort | mechanisms of immunosuppressive tumor evasion: focus on acute lymphoblastic leukemia |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636671/ https://www.ncbi.nlm.nih.gov/pubmed/34867958 http://dx.doi.org/10.3389/fimmu.2021.737340 |
work_keys_str_mv | AT jimenezmoralessilvia mechanismsofimmunosuppressivetumorevasionfocusonacutelymphoblasticleukemia AT arandauribeivansammir mechanismsofimmunosuppressivetumorevasionfocusonacutelymphoblasticleukemia AT perezamadocarlosjhovani mechanismsofimmunosuppressivetumorevasionfocusonacutelymphoblasticleukemia AT ramirezbellojulian mechanismsofimmunosuppressivetumorevasionfocusonacutelymphoblasticleukemia AT hidalgomirandaalfredo mechanismsofimmunosuppressivetumorevasionfocusonacutelymphoblasticleukemia |